Slone Partners Recruits CEO for Syra Health
March 11, 2026 – Life sciences-focused search firm Slone Partners has placed Gregory R. Alexander as CEO at Syra Health, a healthcare technology company dedicated to powering better health outcomes through prevention-focused, accessible, and affordable solutions. “Gregory Alexander is a highly respected leader in the industry, having led several major healthcare initiatives and driving positive change for high-profile organizations throughout his impressive career,” said Sona Stroud, senior vice president, executive search, and partner at Slone Partners. “He will be a tremendous addition to the company’s leadership team as the company amplifies its efforts to accelerate growth and expand its market presence.”
“Greg’s exceptional track record includes expanding markets, tripling sales, and achieving #1 industry rankings at billion-dollar healthcare organizations,” said Avutu Reddy, speaking on behalf of the Syra Health board of directors. “We believe his deep expertise in Medicare, Medicaid, and population health, combined with the discipline he developed as a U.S. Marine Corps officer, positions him to accelerate our growth strategy and deliver meaningful value for shareholders, clients, and the communities we serve.”
Mr. Alexander’s career has been defined by consistently driving growth and exceeding financial targets. A C-suite executive with more than two decades of P&L experience, he has led high-impact growth initiatives, directed operational excellence, and spearheaded strategic change across managed care, population health, and healthcare technology organizations. His leadership approach was shaped through service in the United States Marine Corps, where he served as battalion communications officer and completed multiple tours of duty.
Related: Slone Partners Recruits CEO for Magnetic Insight
Most recently, Mr. Alexander served as SVP of commercial at Ellipsis Health, a voice AI company serving the healthcare and life sciences industries. Prior to that, as chief growth officer at CitizensRx, a $500 million pharmacy benefits manager, Alexander implemented a targeted growth strategy and tripled sales while judiciously managing budgets. At Lumeris, a $1.5 billion population health company, he expanded operations from three to 11 markets while growing Medicare Advantage membership by more than 20 percent annually.
Nationally Recognized
Slone Partners is a nationally recognized senior-level recruitment provider that specializes in delivering executive, management, and leadership talent for the diagnostic, biopharmaceutical, healthcare information technology, and laboratory testing industries. The firm has offices in Boston, New York, Washington, D.C., and San Francisco. Recently, Slone Partners was included among Hunt Scanlon Media’s “Top 50 Healthcare & Life Sciences Search Firms.”
Slone Partners Recruits Chief Business Officer for Vertero Therapeutics
Slone Partners has assisted in the recruitment of Jeffrey S. Kasten as chief business officer of Vertero Therapeutics, a clinical-stage biotechnology company breaking barriers in neurodegenerative disease treatment. “Jeffrey Kasten brings a deep and diversified business development and strategic management skill set to Vertero as the company expands its portfolio of therapies designed to help physicians better manage neurodegenerative diseases and help patients live longer, more productive lives,” said Sona Stroud, senior vice president, executive search, and partner at Slone Partners. “He will be an excellent addition to the company’s leadership team and a valuable partner in its efforts to develop new partnerships and execute successful new product rollouts.”
In 2000, Adam Slone founded Slone Partners and acted as CEO from 2000 to 2016. He remains chairman today. His industry knowledge and extensive contacts have enabled Slone Partners to place thousands of executives and industry professionals. Today, Mr. Slone remains engaged with Slone Partners, with a specific focus in strategy, finance, M&A advisement, and business development in Boston and California.
Leslie Loveless has nearly 20 years of healthcare industry and executive search experience to Slone Partners. She joined the firm in 2007, became COO in 2014 and CEO in 2016. At Slone Partners, Ms. Loveless acts as the leader of the organization as well as the head of the executive search team. Her involvement with clients and candidates enables her to understand the key motivations of each. As CEO, Ms. Loveless’ focus extends to cultivating new business partnerships and expanding relationships with existing clients. Through her leadership, life sciences and biotechnology have emerged as the primary client base for Slone Partners.
With more than 20 years of experience in healthcare and life sciences, Ms. Stroud has extensive market knowledge and a track record of key executive and leadership placements across multiple verticals and a wide array of companies. Before joining Slone Partners in 2011, she spent nearly a decade with Pfizer.
Related: Slone Partners Recruits Chief Business Officer for 1910 Genetics
Contributed by Scott A. Scanlon, Editor-in-Chief and Dale M. Zupsansky, Executive Editor – Hunt Scanlon Media
